london  oct   reuters    officials from the u s  government s health research agency are to be questioned by a congressional committee about why taxpayers are funding a world health organization cancer agency facing criticism over how it classifies carcinogens  an aide to the u s  house committee on oversight and government reform told reuters that national institutes of health officials have agreed to give an in person briefing to the committee after questions were raised by lawmakers over its grants to the international agency for research on cancer  iarc   a semi autonomous part of the who based in lyon  france  the hearing will be in private  with nih officials answering questions from committee investigators  the aide said   the committee is working with the nih to schedule the briefing soon  the aide said  but no date has yet been set   the briefing comes after the committee s chairman added his voice to growing concerns among some senior u s  lawmakers about the way iarc reviews and classifies substances  in recent years iarc has caused controversy over whether such things as coffee  mobile phones  processed meat and the weed killer glyphosate cause cancer  its critics  including in industry  say it is sometimes too quick to conclude that substances might cause cancer  causing unnecessary health scares  it defends its methods as scientifically sound  in a sept   letter to nih director francis collins  oversight committee chairman jason chaffetz describes iarc as having  a record of controversy  retractions  and inconsistencies  and asks why the nih  which has a   billion annual budget  continues to fund it    iarc s standards and determinations for classifying substances as carcinogenic  and therefore cancer causing  appear inconsistent with other scientific research  and have generated much controversy and alarm   chaffetz wrote  the nih confirmed in an email to reuters that it had received chaffetz s letter and  will respond directly to the committee   the who referred reuters to iarc for comment  a spokeswoman for iarc told reuters that chaffetz s letter contained  misconceptions  which iarc s director  chris wild  has sought to address in a letter of his own to the nih director  wild s letter  dated oct   and copied via email to reuters on thursday  rejects chaffetz s criticisms and says iarc s classifications  known as  monographs   are  widely respected for their scientific rigor  standardized and transparent process and     freedom from conflicts of interest   wild also defends iarc s evaluation of coffee and disputed chaffetz s description of it as a  retraction   iarc s previous assessment of coffee as  possibly carcinogenic  was updated in june this year  when iarc said it had found  no conclusive evidence for a carcinogenic effect    the  coffee  report in  was not a  retraction  but a re evaluation based on an additional  years of scientific evidence   wild said  chaffetz  however  asks the nih to detail its standards for awarding grants and the vetting and oversight of grantees  it also asks for full disclosure of nih funds to iarc or money spent in relation to iarc s activities  questions over grants awarded by nih to iarc could put a significant portion of iarc s funding at risk  iarc s resources are relatively modest  its  revenue was about  million euros    million   in his letter  chaffetz s cites the nih s grant database as showing that it has given iarc more than    million so far this year  the database also shows that since   nih grants to iarc have totaled some   million  the american chemistry council also joined those voicing concern  issuing a statement following chaffetz s letter accusing iarc of  a long history of passing judgment on substances through a fundamentally flawed process that yields questionable results    we welcome the interest of the house committee     and hope it will shed light on the close and somewhat opaque relationship between iarc and nih  including the use of taxpayer dollars and resources to support iarc s activities   it said  iarc is also in dispute with the european food safety authority  efsa  and united nations and united states regulators over glyphosate  a widely used weedkiller developed by monsanto   iarc says glyphosate is  probably carcinogenic   while efsa and several other regulators say it isn t   this dispute prompted robert aderholt  chairman of the u s   congressional appropriations subcommittee on agriculture  to write in june to nih s collins questioning funding of iarc  in that letter  aderholt says iarc s conclusions  appear to be the result of a significantly flawed process  and adds that  some in academia have raised questions about the quality of the science and the transparency of the process    the glyphosate dispute also held up a decision on whether to relicense the product for use in europe         euros  